| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Schwartz Center for Metabolism & Nutrition, MetroHealth Medical Center, Cleveland (PSP, SD, LLG, SBA, RWH, and SCK), and the Departments of Pediatrics (PSP, SD, LLG, RWH, and SCK) and Biochemistry (RWH), Case Western Reserve University School of Medicine, Cleveland.
Background: Glutamine is a critical amino acid for the metabolism of enterocytes, lymphocytes, and other proliferating cells. Although supplementation with glutamine has been suggested for growing infants, its effect on protein metabolism has not been examined.
Objective: The objective was to examine the effect of enteral glutamine or glycine on whole-body kinetics of glutamine, phenylalanine, leucine, and urea in preterm infants.
Design: Infants at <32 wk of gestation were given formula supplemented with either glutamine (0.6 g · kg-1 · d-1; n = 9) or isonitrogenous amounts of glycine (n = 9) for 5 d. Eight infants fed unsupplemented formula served as control subjects. Glutamine, phenylalanine, leucine nitrogen flux, leucine carbon flux, and urea kinetics were quantified during a basal fasting period and in response to nutrient intake.
Results: Growing preterm infants had a high weight-specific rate of appearance of glutamine, phenylalanine, and leucine nitrogen flux. When compared with the control treatment, enteral glutamine resulted in a high rate of urea synthesis, no change in the plasma glutamine concentration, and no change in the rate of appearance of glutamine. Glycine supplementation resulted in similar changes in nitrogen metabolism, but the magnitude of change was less than that in the glutamine group. In the nonsupplemented infants, the rate of appearance of leucine nitrogen flux was negatively correlated (
= -0.72) with urea synthesis. In contrast, the correlation ( = 0.75) was positive in the glutamine group.
Conclusion: Enterally administered glutamine in growing preterm infants is entirely metabolized in the gut and does not have a discernable effect on whole-body protein and nitrogen kinetics.
Key Words: Glutamine • glycine • premature infants • leucine • urea • phenylalanine • reamination • growth
This article has been cited by other articles:
|
|
 |
|
  A. van den Berg, A. van Zwol, H. A. Moll, W. P. F. Fetter, and R. M. van Elburg Glutamine-Enriched Enteral Nutrition in Very Low-Birth-Weight Infants: Effect on the Incidence of Allergic and Infectious Diseases in the First Year of Life Arch Pediatr Adolesc Med, November 1, 2007; 161(11): 1095 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mok, C. E.-D. Violante, C. Daubrosse, F. Gottrand, O. Rigal, J.-E. Fontan, J.-M. Cuisset, J. Guilhot, and R. Hankard Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy. Am. J. Clinical Nutrition, April 1, 2006; 83(4): 823 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Kadrofske, P. S. Parimi, L. L. Gruca, and S. C. Kalhan Effect of intravenous amino acids on glutamine and protein kinetics in low-birth-weight preterm infants during the immediate neonatal period Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E622 - E630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Kalhan and P. S. Parimi Transamination of Leucine and Nitrogen Accretion in Human Pregnancy and the Newborn Infant J. Nutr., January 1, 2006; 136(1): 281S - 287S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. van den Berg, R. M van Elburg, E. A. Westerbeek, J. W. Twisk, and W. P. Fetter Glutamine-enriched enteral nutrition in very-low-birth-weight infants and effects on feeding tolerance and infectious morbidity: a randomized controlled trial Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1397 - 1404. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
